Animal Pharm is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. Please do not redistribute without permission.

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Pharmaceuticals

Set Alert for Pharmaceuticals

'Factory farms' are stoking increased antibiotic resistance and animal welfare issues in Asia

Asia's shift towards more intensive farming is creating a platform for a wide-range of concerns for animal health.

Asia Pacific Pharmaceuticals

ImmuCell sales drop in Q2 as First Defense passes peak

US animal health firm ImmuCell has seen its sales dip by 26% in the second quarter of 2017.

Financial Results R&D

KindredBio's atopic dermatitis monoclonal antibodies pique partner interest

Kindred Biosciences has said its pipeline of monoclonal antibodies (mAbs) are causing a stir among potential commercial collaborators.

Pharmaceuticals Dermatology

Zoetis chewable antibiotic for pets launched in US

Zoetis has launched the chewable version of its Clavamox antibiotic for dogs and cats in the US.

United States Canine

FDA to utilize biomass for antimicrobial data

The US FDA hopes to use a biomass denominator as part of its quest for more accurate annual data concerning the level of antimicrobials sold or distributed for use in food-producing animals.

FDA United States

ECO gets Turkish registration for Aivlosin in poultry

ECO Animal Health has added another authorization to its Aivlosin antibiotic portfolio, with Turkey the latest country to approve the product for use in commercial layers.

Turkey Pharmaceuticals

Merck topical cattle treatment approved in US

Merck Animal Health has gained US FDA approval for a respiratory and pain treatment for cattle.

United States Merck MSD Animal Health

AntriaBio, ActiveSite sign development deal for inhibitor portfolio

US firms AntriaBio and ActiveSite Pharmaceuticals have signed a license and development agreement for oral plasma kallikrein inhibitors.

Deals R&D

EU report shows more evidence of link between antibiotic use, resistance

A new report from the European Food Safety Authority (EFSA), the European Medicines Agency and the European Centre for Disease Prevention and Control has drawn the link between antibiotic consumption and antibiotic resistance in both humans and animals, with more complete data compared to a similar report in 2015.

Europe European Commission

CVMP proposes restrictions on aminoglycosides

The European Medicines Agency (EMA) is taking a closer look at the use of aminoglycosides in animals to reduce the risk of antimicrobial resistance. 

Policy & Regulation Pharmaceuticals

Japan approves Virbac's otitis treatment for dogs

The Japanese Ministry of Agriculture, Forestry and Fisheries (JMAFF) has approved Virbac Japan's EasOtic (hydrocortisone aceponate, miconazole nitrate, gentamicin sulphate) to treat infectious external otitis in dogs. 

Pharmaceuticals Generics

A carousel of companies: Inside the industry consolidation of 1990-2000

With the animal health sector currently experiencing a temporary lull in major M&A deals, the recent company rankings have remained fairly stable. However, to understand today's industry landscape, a history of consolidation has to be reviewed. Editor Joseph Harvey dug up Animal Pharm's time capsule to inspect over 25 years of comings and goings. 

M&A Markets
See All
Advertisement
UsernamePublicRestriction

Register